Literature DB >> 17384914

Myogenous sarcoma of the gallbladder with a hemangiopericytomatous pattern.

Gerd Nestler1, Zuhir Halloul, Matthias Evert, Frank Dombrowski, Hans Lippert, Frank Meyer.   

Abstract

Primary sarcoma of the gallbladder is a very rare neoplasm, and there are few instances of its diagnostic and therapeutic management. We describe a 66-year-old male patient with a sarcoma of the gallbladder. He initially underwent a laparoscopic cholecystectomy, converted to an open procedure. Histology showed a primary sarcoma of the gallbladder (NOS). A relaparotomy, with resection of the cystic stump, anatomical hepatic resection of the fifth segment, including the bed of gallbladder, and lymphadenectomy was performed a few days later. The two surgical interventions were done with no major complications, and a radical resection status was achieved. Histological investigation revealed a malignant mesenchymal tumor lesion, which was classified as a myogenous sarcoma with a hemangiopericytomatous pattern. After an 11-month, uneventful, postoperative course, local tumor recurrence was diagnosed. Palliative chemotherapy was scheduled, but the patient died of advanced tumor recurrence 10 days after this diagnosis. Despite a poor overall prognosis, extensive surgical resection is favored for myogeneous sarcoma of the gallbladder; this procedure is based on precise clarification of the histopathological diagnosis, and can be followed by attempts with radiation of chemotherapy if early diagnosis-finding has failed. This approach allowed, in our patient with this rare neoplasm, a remarkable tumor-free survival of almost 1 year.

Entities:  

Mesh:

Year:  2007        PMID: 17384914     DOI: 10.1007/s00534-006-1130-4

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  1 in total

1.  Primary leiomyosarcoma of gallbladder: a rare diagnosis.

Authors:  Ajay Savlania; Arunanshu Behera; Kim Vaiphei; Harjeet Singh; R K Dhiman; Ajay Duseja; Y K Chawla
Journal:  Case Rep Gastrointest Med       Date:  2012-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.